medigraphic.com

2007, Number 3

<< Back Next >>

Rev Hosp Jua Mex 2007; 74 (3)

Haemodynamics a successful alternative for totipotent cells administration in heart disease and diabetes type II

Sánchez CAR, Acosta AG, Carrasco JA, Cuneo S

Language: Spanish
References: 18
Page: 186-190
PDF size: 49.13 Kb.


ABSTRACT

In Mexico, million individuals present cardiovascular, renal, of the nervous system diseases and diabetes mellitus. The treatment for these chronic-degenerative sufferings, that imply the function loss of different organs or weaves, is basically pharmacological; in some cases the transplant of organs represents a good therapeutic alternative. The implant of autologous stem cells represents a new strategy for functional cells renovation. In Hospital Juarez de Mexico, an hematologists, immunologists and interventionist cardiologists multidisciplinary group, made two first cases of autologous stem cells implant in a pediatric patient with inability and refractory to pharmacological treatment cardiopathy and in a patient with diabetes mellitus type 2 with three years of evolution. In both cases concentrated of stem cells was administered by catheters through femoral artery until arriving at coronary arteries proximity, in the cardiopathy case and until the celiac trunk and superior mesenteric in the case of the patient with diabetes mellitus. At the moment, the physical activity of the patient with cardiopathy has improved and in infuctional class I of the NYHA; the patient with diabetes type II presents important insulin and peptide elevations and does not require administration of sulfonylureas.


REFERENCES

  1. Soria B. In-vitro differentiation of pancreatic b-cells. Differentiation 2001; 68: 205-19.

  2. Soria B, Andreu E, Berná G, Fuentes E, Gil A, León-Quinto T, et al. Engineering Pancreatic Islets Pflügers Archiv- Eur. J Physiol 2000; 440: 1-18.

  3. Andreea L, George G, Holz ND. Mehboob A. In vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusión. J Clin Invest 2003; 111: 843-50.

  4. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.

  5. Grossman JD, Grossman W. Angiogénesis. Rev Cardiovasc Med 2002; 3: 138-44.

  6. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams W, et al. Expression of VEGFR-2 and AC133 by circulating human CD341 cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-8.

  7. Bonaros N, Yang SH, Kocher OA, Song A. Cell therapy for the ischemic for heart disease. Panminerva Médica 2004; 46: 13-23.

  8. Fernández VJ, Saslavsky L, Camozzi L, Ferreira da Silva J, Vrsalovic AO, Saslavsky M. Sustained effect of autologous bone marrow mononuclear cells infusion in children with type 1 diabetes: six-month follow-up results. Sydney Australia; June 24-27, 2004.

  9. Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, et al. Local Implantation of Autologous Bone Marrow Cells for Therapeutic Angiogenesis in Patients With Ischemic Heart Disease Clinical Trial and Preliminary Results. Jpn Circ J 2001; 65: 845-7.

  10. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets. Science 2001; 292: 1389-94.

  11. Sistema Nacional de Vigilancia Epidemiológica. Sistema único de información. Epidemiología 2001. www.epi.org.mx (en línea).

  12. Shapiro J. Clinical Islet transplantation: advances and inmunological challenges. Nat Rev Inmunol 2004; 4: 259-68.

  13. Shapiro J. International Trial of the Edmonton Protocol for Islet Transplantation. NEJOM 2006; 55: 1318-30.

  14. Soria B, Roche E, Berná G, León-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem-cells normalize glycaemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49: 157-16.

  15. Soria B, Skoudy A, Martin F. From stem cells to?-cells: new strategies in cell therapy of diabetes mellitus. Diabetes 2000; 44: 407-15.

  16. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg V, et al. Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell transplantation in Humans. Circulation 2002; 106: 1913-18.

  17. Taylor DA. Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr Control Trials Cardiovasc Med 2001; 2: 208-10.

  18. Wild S, Roglic G, Green A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.




2020     |     www.medigraphic.com